Showing 621 - 640 results of 107,009 for search '(( e mean decrease ) OR ( 5 ((((step decrease) OR (nn decrease))) OR (a decrease)) ))', query time: 1.25s Refine Results
  1. 621
  2. 622

    Five main steps of MATSim. by Jingfa Ma (20396406)

    Published 2024
    “…Results indicate that enhancements in vehicle range and charging efficiency slightly decrease the use of autonomous vehicles by 2.5%, as the existing vehicle specifications already meet daily travel needs in Shanghai. …”
  3. 623
  4. 624
  5. 625
  6. 626
  7. 627
  8. 628

    <i>Ext1</i> mutant lungs exhibit a decrease in SHH-FGF10 signaling. by Hua He (120374)

    Published 2017
    “…<p>(A) qPCR analysis of key components of FGF signaling pathway in lungs from E14.5. …”
  9. 629
  10. 630
  11. 631
  12. 632
  13. 633

    Changes in neural activity were decreased in animals pre-exposed to 5-HT and <i>mod-1</i> mutants when the worms switched their locomotive direction. by Haruka Mori (8082215)

    Published 2019
    “…<p>(A–F) the neural activity of the RID changes during the transition periods from backward to forward locomotion (A–C) and from forward to backward locomotion (D–F) in the mock (A: p = 1.5 × 10<sup>−5</sup>; D: p = 5.5 × 10<sup>−13</sup>), 5-HT exposed (B: p = 0.092; E: p = 0.79), and <i>mod-1</i> mutant (C: p = 0.081; F: p = 0.93) groups. …”
  14. 634
  15. 635
  16. 636

    Decreased dermal and corneal stromal collagen in <i>Slc39a13</i>-KO mice. by Toshiyuki Fukada (156297)

    Published 2008
    “…H&E staining shows 5-week-old <i>Slc39a13</i>-KO skin is thinner than wild-type littermates (left), without significant difference in epidermis (right; enlarged view of blue-boxed area 1). …”
  17. 637
  18. 638
  19. 639
  20. 640

    Blocking TNF or IL-6 decreases HIV-1 replication significantly in a dose dependent manner. by Shahin Ranjbar (66979)

    Published 2013
    “…Blocking TNF (at 2 ug/ml or 5 ug/ml) or IL-6 (5 ug/ml) significantly decreased virus replication (*, p<0.05) as compared to the same concentrations of an IgG<sub>1</sub> control antibody. …”